Jan R. BoehnkeFeb 19

Quality Assessment of Diagnostic Test Accuracy Studies

QUADAS-3 published:
https://pubmed.ncbi.nlm.nih.gov/41698208/

__Key changes from QUADAS-2__

introduction of an 'ideal test accuracy trial'

assessment at the estimate rather than study level

"Flow and Timing" domain replaced with an "Analysis" domain

sections on the rationale for judgments

introduction of a judgment of #RiskOfBias and concerns regarding applicability

#Psychometrics #SysReview #RoB

LATITUDES NetworkDec 6, 2024
#HelloWorld, we are now on @Mastodon! Please follow us if you want to learn more about the #ValidityAssessment (#RiskOfBias) for #EvidenceSyntheses such as #SystematicReviews. #firstpost
Ross MounceNov 19, 2023

Haven't blogged in a long long time.

But I just about found time tonight to write a tiny bit more about PCI Registered Reports (@pcirr) and a recent peer-review experience that made me realise the community need for PCI Registered Reports:
https://rossmounce.co.uk/2023/11/19/kudos-to-pci-registered-reports/

#OpenScience #Metaresearch #PeerReview #ExperimentalDesign #RiskOfBias

Kudos to PCI Registered Reports - Ross Mounce

This is just a quick post of appreciation for PCI Registered Reports. I’ve recently joined the PCI RR community as a ‘recommender‘. One thing that spurred me to join is a rather unsatisfactory experience I had as a peer-reviewer, reviewing a manuscript where the experimental design was deeply insufficient. I won’t reveal for which open […]

Ross Mounce
Armine AbrahamyanMay 5, 2023

#RiskofBias in #prevalence studies in #epidemiology. Sharing experiences at #Harmony #CostAction workshop.

📅 May 2-3, 2023
📍Athens, Greece

Show threadkdnyhanNov 27, 2022
@petersuber Climbing down from my #reporting high horse for a moment: I note that the Serohub people don't do a #RiskOfBias assessment. On the one hand, I get it - that would add a lot of complexity to the process. On the other, check out the stated goal. Do you think policymakers, local public health officials, and "the public" have the sophisticated research design knowledge to critically appraise seroprevalence studies for selection bias etc?